4642. Tryptacin tablets (47 seizure actions). (F. D. C. Nos. 35667, 35669, 35670, 35679, 35682/6, 35690, 35693, 35695, 35703, 35709/12, 35715, 35721, 35725, 35726, 35728, 35729, 36022/5, 36030/3, 36035/8, 36041/3, 36045/53, 36055, 36056, 36067, 36068, 36073, 36091/3. S. Nos. 14-743 L, 17-595 L, 19-848 L, 20-097/9 L, 20-104 L, 20-110 L, 35-520/1 L, 35-527/8 L, 39-554 L, 39-562 L, 42-630 L, 42-891/3 L, 43-163 L, 43-165/6 L, 43-169/70 L, 43-313/4 L, 47-921 L, 48-106/7 L, 58-253/5 L, 58-257 L, 58-260/2 L, 59- 184/5 L, 59-392/6 L, 64-364 L, 65-375/6 L, 70-052 L, 72-361 L, 73-S88/90 L, 75-976 L, 83-473/4 L, 83-^77 L, 83-481L, 83-855 L.) •See also No. 4641. 90 FOOD, DRUG, AND COSMETIC ACT [D..l>. N. J, Minn.; Los Angeles, Oakland, San Francisco, Sacramento, and Vernon, Calif.; Chicago, Ill.; Philadelphia, Pa.; Tampa, Fla.; Charleston, W. Va.; New Orleans, La.; Denver, Colo.; Burlington, Des Moines, Cedar Rapids, Ottumwa, and Waterloo, Iowa; Everett and Seattle, Wash.; and Houston, Tex. SHIPPED: Between 1-13-53 and 10-9-53, from Cleveland, Ohio, by Rhodes Pharmacal Co., Inc. LABEL IN PART: (Btl.) "Tryptacin Rhodes * * * Tablets." RESULTS OF INVESTIGATION : Advertisements concerning the use of the. article in the treatment of stomach ulcers appeared in various newspapers circulated in the areas where the product was located, but the labeling of the article bore no reference to stomach ulcers. LIBELED: Between 9-24-53 and 11-10-53, N. Dist. Ga., Dist. Minn., N. Dist. Calif., S. Dist. Calif., N. Dist. Ill., E. Dist. Pa., S. Dist. Fla., S. Dist. W. Va., E. Dist. La., Dist. Colo., N. Dist. Iowa, S. Dist. Iowa, W. Dist. Wash., and S. Dist. Tex. CHARGE: 502 (f) (1)—the labeling of the article when shipped failed to state all the conditions or diseases for which the article was intended to be taken, and its labeling failed also to bear adequate directions for use in the treatment of such conditions and diseases. DISPOSITION : Between 11-6-53 and 8-16-54. 4 seizure actions: Default— destruction. 43 seizure actions: Consent—Claimed by Rhodes Pharmacal Co., Inc., and relabeled.